Back to news

ICON plc (ICLR) rises as investors look ahead to late-October earnings, though a single clear catalyst is not obvious

Investivoq PriceTracker

ICON plc (ICLR) is up 6.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be a momentum move into the company’s upcoming third-quarter earnings report, with investors positioning ahead of results due after the market close on October 27, 2026. A single company-specific headline tied directly to today’s jump is not obvious, so part of the move could also reflect renewed confidence after recent analyst target support and the company’s maintained full-year outlook.

Details:

  • ICON said on October 8 that it will report third-quarter 2026 financial results after the market close on October 27, with a webcast set for October 28.
  • In second-quarter results released July 29, the company reaffirmed 2026 guidance for revenue of $7.85 billion to $8.15 billion and adjusted diluted earnings per share of $10.00 to $11.00.
  • That same quarterly update showed net business wins of $3.12 billion, a 1.51 book-to-bill ratio, and backlog of $23.4 billion, which may support a more constructive setup into the next report.
  • Recent published analyst data also points to targets above the stock’s earlier October trading levels, which could be helping sentiment even without a fresh confirmed headline today.

    • Sources:

    ICON plc, SEC, MarketBeat

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $ICLR Insider Trading Activity

    ICLR Insider Trades

    $ICLR insiders have traded $ICLR stock on the open market 37 times in the past 6 months. Of those trades, 0 have been purchases and 37 have been sales.

    Here’s a breakdown of recent trading of $ICLR stock by insiders over the last 6 months:

    • JOHN DR CLIMAX has made 0 purchases and 5 sales selling 5,846 shares for an estimated $1,014,043.
    • RONAN MARTIN MURPHY has made 0 purchases and 5 sales selling 5,846 shares for an estimated $1,014,042.
    • EUGENE PACELLI MCCAGUE has made 0 purchases and 5 sales selling 4,096 shares for an estimated $707,792.
    • CIARAN MURRAY has made 0 purchases and 4 sales selling 2,677 shares for an estimated $439,803.
    • NIGEL BERNARD JOHN CLERKIN (Chief Financial Officer) has made 0 purchases and 4 sales selling 2,267 shares for an estimated $372,444.
    • JULIE O'NEILL has made 0 purchases and 4 sales selling 915 shares for an estimated $150,326.
    • LINDA GRAIS has made 0 purchases and 4 sales selling 841 shares for an estimated $138,168.
    • ANNE CLEM WHITAKER has made 0 purchases and 4 sales selling 841 shares for an estimated $138,167.
    • BARRY EDWARD BALFE (Chief Executive Officer) has made 0 purchases and 2 sales selling 382 shares for an estimated $62,676.

    To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

    Investivoq Alerts
    Receive ICLR Data Alerts
    Get market-moving data, filings, and signals for ICLR in real time.
    Sign Up

    $ICLR Hedge Fund Activity

    We have seen 212 institutional investors add shares of $ICLR stock to their portfolio, and 210 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • INVESCO LTD. added 1,385,367 shares (+35.7%) to their portfolio in Q2 2026, for an estimated $240,652,101
    • MADISON AVENUE PARTNERS, LP removed 1,282,838 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $222,841,788
    • GREENHAVEN ASSOCIATES INC added 1,098,204 shares (+54.8%) to their portfolio in Q2 2026, for an estimated $190,769,016
    • FMR LLC added 1,097,315 shares (+26.3%) to their portfolio in Q2 2026, for an estimated $190,614,588
    • AMERIPRISE FINANCIAL INC added 877,359 shares (+858.2%) to their portfolio in Q2 2026, for an estimated $152,406,031
    • MAPLE ROCK CAPITAL PARTNERS INC. added 864,300 shares (+257.8%) to their portfolio in Q2 2026, for an estimated $150,137,553
    • HOLOCENE ADVISORS, LP removed 840,845 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $146,063,184

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $ICLR Congressional Stock Trading

    Members of Congress have traded $ICLR stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

    Here’s a breakdown of recent trading of $ICLR stock by members of Congress over the last 6 months:

    • REPRESENTATIVE KEVIN HERN sold up to $50,000 on 08/14.

    To track congressional stock trading, check out Investivoq's congressional trading dashboard. You can access data on congressional stock trades through the Investivoq API Congress trades endpoint.

    $ICLR Price Targets

    Multiple analysts have issued price targets for $ICLR recently. We have seen 11 analysts offer price targets for $ICLR in the last 6 months, with a median target of $185.0.

    Here are some recent targets:

    • Jailendra Singh from Truist Securities set a target price of $207.0 on 06/30/2026
    • Ann Hynes from Mizuho set a target price of $190.0 on 06/26/2026
    • Michael Ryskin from B of A Securities set a target price of $150.0 on 06/25/2026
    • Eric Coldwell from Baird set a target price of $186.0 on 06/25/2026
    • Ross Muken from Evercore ISI Group set a target price of $180.0 on 06/25/2026
    • Luke Sergott from Barclays set a target price of $175.0 on 06/25/2026
    • Ryan Halsted from RBC Capital set a target price of $185.0 on 06/25/2026

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.